title: Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents.
abstract: BACKGROUND
  Advances in medical technology and research documenting clinical effectiveness have led to the increased use of insulin pumps worldwide. However, their use by children in the UK is relatively limited and there is little evidence regarding their impact on patients' lives.
  
  
  OBJECTIVE
  This study aimed to examine the impact of switching from multiple daily injections to insulin pumps on the glycaemic control and daily lives of children/young people and their families.
  
  
  METHODS
  University College London Hospital, London.
  
  
  METHODS
  Face-to-face semi-structured interviews were conducted with children/young people with type 1 diabetes mellitus (5-17 years; N = 34) and their parents (N = 38), receiving insulin pump therapy and attending paediatric diabetes outpatients clinics at a major university teaching hospital in London. Glycated haemoglobin A1c values from 6 months prior to, and after pump therapy were obtained. Qualitative and quantitative approaches were undertaken for data analysis.
  
  
  METHODS
  Glycated haemoglobin A1c and the impact of the use of insulin pumps on the children and their families.
  
  
  RESULTS
  The majority of parents (N = 32) and the children/young people (N = 30) reported that glycaemic control was easier to maintain within the target range with pumps compared to injections. This was supported by glycated haemoglobin A1c measures. Participants generally found the devices easy to use and more acceptable than injections. However, parents and children/young people reported many challenges in the early stages of pump therapy (e.g. 7 children/young had worse control at 6 months after starting CSII). Parents and children/young people reported an overall increase in lifestyle flexibility and an improved ability to participate in home, school and social activities whilst maintaining glycaemic control.
  
  
  CONCLUSIONS
  Administration of insulin via pumps rather than injections was generally preferred. Participants reported most difficulty at the commencement of use. Pump therapy conferred benefits in terms of glycaemic control, general well-being, enabling young people to be more in control of their condition and live more normal lives, as reported by most participants. These are important goals of health policy for children/young people with long-term conditions in the UK.
authors.affiliation: Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriyah, P.O. Box: 24923, Safat, 13110, Kuwait, fatemah.alsaleh@hsc.edu.kw.
authors.forename: Fatemah M
authors.initials: FM
authors.lastname: Alsaleh
authors.forename: Felicity J
authors.initials: FJ
authors.lastname: Smith
authors.forename: Rebecca
authors.initials: R
authors.lastname: Thompson
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Al-Saleh
authors.forename: Kevin M G
authors.initials: KM
authors.lastname: Taylor
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007332:Insulin Infusion Systems / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D010290:Parents / Q000523:psychology*; D017060:Patient Satisfaction; D011788:Quality of Life
chemical_list: D006442:Glycated Hemoglobin
references.citation: Pediatr Diabetes. 2001 Jun;2(2):51-7
references.pmid: 15016198
references.citation: J Clin Pharm Ther. 2010 Apr;35(2):127-38
references.pmid: 20456732
references.citation: Pediatr Diabetes. 2006 Feb;7(1):25-31
references.pmid: 16489971
references.citation: Diabetologia. 2013 Nov;56(11):2392-400
references.pmid: 23963323
references.citation: Diabet Med. 2010 Mar;27(3):339-47
references.pmid: 20536498
references.citation: Health Technol Assess. 2010 Feb;14(11):iii-iv, xi-xvi, 1-181
references.pmid: 20223123
references.citation: Pediatr Diabetes. 2009 Feb;10(1):52-8
references.pmid: 18761648
references.citation: J Pediatr Endocrinol Metab. 2003 Mar;16(3):393-9
references.pmid: 12705364
references.citation: Pediatr Diabetes. 2005 Mar;6(1):17-21
references.pmid: 15787897
references.citation: Diabet Med. 2006 Aug;23(8):900-6
references.pmid: 16911629
references.citation: J Clin Res Pediatr Endocrinol. 2012 Sep;4(3):127-31
references.pmid: 22985612
references.citation: J Nurs Scholarsh. 2004;36(4):316-23
references.pmid: 15636411
references.citation: J Clin Pharm Ther. 2012 Apr;37(2):140-7
references.pmid: 21729118
references.citation: Pediatr Diabetes. 2005 Mar;6(1):22-31
references.pmid: 15787898
references.citation: Paediatr Nurs. 2008 Mar;20(2):14-8
references.pmid: 18350856
references.citation: Diabet Med. 2007 Jun;24(6):607-17
references.pmid: 17367304
references.citation: Pediatrics. 2004 Dec;114(6):1601-5
references.pmid: 15574621
references.citation: Diabet Med. 2011 Sep;28(9):1109-12
references.pmid: 21843306
references.citation: Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S109-14
references.pmid: 20515298